NASDAQ:AUPH   Aurinia Pharmaceuticals Inc
Phase 3 Trial News about to be released within 2 weeks, most likely first week of December

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.